Concepedia
Author
Rebecca H. Boucher
Also Known As
R Boucher, R. Boucher, Rebecca Boucher, Rebecca H. Boucher
36
Publications
1.3K
Citations
9
H-Index
0
Concepts
All Affiliations
×
All Concepts
7
517
Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study
Peter Hillmen, Andy C. Rawstron, Kristian Brock, +16
Journal of Clinical Oncology
2019
264
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial
Claire Harrison, Jyoti Nangalia, Rebecca H. Boucher, +29
2023
123
Targeted deep sequencing of urothelial bladder cancers and associated urinary <scp>DNA</scp> : a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification
Douglas G. Ward, Naheema S. Gordon, Rebecca H. Boucher, +17
British Journal of Urology
54
The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease
Niamh Appleby, Toby A. Eyre, Maité Cabes, +6
BMC Cancer
32
Continued Long Term Responses to Ibrutinib + Venetoclax Treatment for Relapsed/Refractory CLL in the Blood Cancer UK TAP Clarity Trial
Peter Hillmen, Rebecca H. Boucher, Nichola Webster, +16
Blood
2020
17
Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers
Ruhana R. Jeeta, Naheema S. Gordon, Laura Baxter, +11
Bladder Cancer
15
MRD4 Eradication at 6 Months and Early Clearance of MRD with Combination of Ibrutinib Plus Venetoclax Results in Sustained Clinical and MRD Responses: Exploratory Analysis of the Blood Cancer UK TAP Clarity Study
Talha Munir, Louise-Rae Cherrill, Nichola Webster, +18
2022
12
Page 1